|
PROSC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91699999999573E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.241710E-04 |
| Normal-vs-Stage2 |
3.058100E-03 |
| Normal-vs-Stage3 |
2.77810000004486E-07 |
| Normal-vs-Stage4 |
4.043300E-03 |
| Stage1-vs-Stage2 |
8.241800E-01 |
| Stage1-vs-Stage3 |
2.137700E-02 |
| Stage1-vs-Stage4 |
9.689600E-01 |
| Stage2-vs-Stage3 |
1.906390E-01 |
| Stage2-vs-Stage4 |
8.927800E-01 |
| Stage3-vs-Stage4 |
1.323450E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.23120000048583E-07 |
| Normal-vs-AfricanAmerican |
1.622560E-01 |
| Normal-vs-Asian |
8.124300E-03 |
| Caucasian-vs-AfricanAmerican |
2.141600E-01 |
| Caucasian-vs-Asian |
2.067000E-01 |
| AfricanAmerican-vs-Asian |
5.900000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.31650000000117E-05 |
| Normal-vs-Female |
4.2019999999976E-05 |
| Male-vs-Female |
4.886200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.044800E-04 |
| Normal-vs-Age(41-60Yrs) |
5.93730000000292E-05 |
| Normal-vs-Age(61-80Yrs) |
9.80600000000109E-05 |
| Normal-vs-Age(81-100Yrs) |
2.479700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.396200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.805400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.338800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.515000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.747800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.233600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.653800E-01 |
| Classical-VS-Follicular |
7.381800E-01 |
| Classical-VS-Other |
8.489800E-01 |
| Classical-VS-Normal |
5.54079999999235E-05 |
| Tall-VS-Follicular |
2.170000E-01 |
| Tall-VS-Other |
7.091800E-01 |
| Tall-VS-Normal |
3.001900E-04 |
| Follicular-VS-Other |
8.008000E-01 |
| Follicular-VS-Normal |
6.518000E-03 |
| Other-VS-Normal |
8.704200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.4163000000006E-05 |
| Normal-vs-N1 |
2.05170000000532E-06 |
| N0-vs-N1 |
1.690770E-01 |
|
|
